Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
20,788,776
-
Share change
-
+3,197,108
-
Total reported value
-
$950,879,909
-
Price per share
-
$45.74
-
Number of holders
-
107
-
Value change
-
+$115,760,357
-
Number of buys
-
67
-
Number of sells
-
47
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q1 2021
As of 31 Mar 2021,
Pulmonx Corp - COM (LUNG) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,788,776 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, RTW INVESTMENTS, LP, Capital World Investors, GILDER GAGNON HOWE & CO LLC, KPCB XIII Associates, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., ABG Innovation Capital Partners III GP Ltd, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
107
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.